Form 8-K Pacira BioSciences, Inc. For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Pacira BioSciences (PCRX) Announces CFO Departure
February 29, 2024 8:15 AM ESTOn February 26, 2024, Pacira BioSciences (NASDAQ: PCRX) and Charles A. Reinhart, III, the Companys Chief Financial Officer, agreed that he will depart the Company, effective September 30, 2024 (the Transition Date). The Company has commenced a search for a successor to Mr. Reinhart.
In connection with his departure and the services Mr. Reinhart will provide during the transition period, the Company and Mr. Reinhart agreed, subject to execution and non-revocation of a customary release of claims against the Company,... More
